APO RESEARCH · REPORT
Omega-3
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Product & engineering
Understand the product.
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Selected research
Market Outlook & Growth Opportunities
Global Omega-3 Market Outlook and Growth Opportunities 2026
Market perspective
Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Global Omega-3 main players are DSM, BASF, Marine Ingredients, OLVEA Fish Oils, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 35%.
This report provides an overview of the global Omega-3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Omega-3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Omega-3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omega-3 market size, projected growth trends, production technologies, key applications, and end-use industries.
Omega-3 Segment by Company
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma (Marine Ingredients)
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Orkla Health
LYSI
OLVEA Fish Oils
Hofseth BioCare
Nippon Suisan Kaisha
Bioprocess Algae
Shandong Yuwang Pharmaceutical
Maruha Nichiro Foods
Solutex
Omega-3 Segment by Type
Marine Omega-3
Algae Omega-3
Omega-3 Segment by Application
Dietary Supplements
Fortified Food and Beverage
Infant Formula
Pharmaceuticals
Pet Foods
Others
Omega-3 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Omega-3 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Omega-3 market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Omega-3 significant trends, drivers, influence factors in global and regions.
6. To analyze Omega-3 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega-3.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Omega-3 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omega-3 industry.
Chapter 3: Detailed analysis of Omega-3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Omega-3 in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Omega-3
- Algae Omega-3
Applications
- Dietary Supplements
- Fortified Food and Beverage
- Infant Formula
- Pharmaceuticals
- Pet Foods
- Others
Companies covered
- DSM
- BASF
- EPAX
- Golden Omega
- TASA
- Omega Protein
- Croda
- KD Pharma (Marine Ingredients)
- GC Rieber
- Polaris
- Auqi
- Kinomega
- Skuny
- Xinzhou
- Anti-Cancer
- Sinomega
- Orkla Health
- LYSI
- OLVEA Fish Oils
- Hofseth BioCare
- Nippon Suisan Kaisha
- Bioprocess Algae
- Shandong Yuwang Pharmaceutical
- Maruha Nichiro Foods
- Solutex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Omega-3 Sales Value (2021-2032)
- 1.2.2 Global Omega-3 Sales Volume (2021-2032)
- 1.2.3 Global Omega-3 Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Omega-3 Market Dynamics
- 2.1 Omega-3 Industry Trends
- 2.2 Omega-3 Industry Drivers
- 2.3 Omega-3 Industry Opportunities and Challenges
- 2.4 Omega-3 Industry Restraints
3 Omega-3 Market by Company
- 3.1 Global Omega-3 Company Revenue Ranking in 2025
- 3.2 Global Omega-3 Revenue by Company (2021-2026)
- 3.3 Global Omega-3 Sales Volume by Company (2021-2026)
- 3.4 Global Omega-3 Average Price by Company (2021-2026)
- 3.5 Global Omega-3 Company Ranking (2024-2026)
- 3.6 Global Omega-3 Company Manufacturing Base and Headquarters
- 3.7 Global Omega-3 Company Product Type and Application
- 3.8 Global Omega-3 Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Omega-3 Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Omega-3 Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Omega-3 Market by Type
- 4.1 Omega-3 Type Introduction
- 4.1.1 Marine Omega-3
- 4.1.2 Algae Omega-3
- 4.2 Global Omega-3 Sales Volume by Type
- 4.2.1 Global Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Omega-3 Sales Volume by Type (2021-2032)
- 4.2.3 Global Omega-3 Sales Volume Share by Type (2021-2032)
- 4.3 Global Omega-3 Sales Value by Type
- 4.3.1 Global Omega-3 Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Omega-3 Sales Value by Type (2021-2032)
- 4.3.3 Global Omega-3 Sales Value Share by Type (2021-2032)
5 Omega-3 Market by Application
- 5.1 Omega-3 Application Introduction
- 5.1.1 Dietary Supplements
- 5.1.2 Fortified Food and Beverage
- 5.1.3 Infant Formula
- 5.1.4 Pharmaceuticals
- 5.1.5 Pet Foods
- 5.1.6 Others
- 5.2 Global Omega-3 Sales Volume by Application
- 5.2.1 Global Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Omega-3 Sales Volume by Application (2021-2032)
- 5.2.3 Global Omega-3 Sales Volume Share by Application (2021-2032)
- 5.3 Global Omega-3 Sales Value by Application
- 5.3.1 Global Omega-3 Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Omega-3 Sales Value by Application (2021-2032)
- 5.3.3 Global Omega-3 Sales Value Share by Application (2021-2032)
6 Omega-3 Regional Sales and Value Analysis
- 6.1 Global Omega-3 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Omega-3 Sales by Region (2021-2032)
- 6.2.1 Global Omega-3 Sales by Region: 2021-2026
- 6.2.2 Global Omega-3 Sales by Region (2027-2032)
- 6.3 Global Omega-3 Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Omega-3 Sales Value by Region (2021-2032)
- 6.4.1 Global Omega-3 Sales Value by Region: 2021-2026
- 6.4.2 Global Omega-3 Sales Value by Region (2027-2032)
- 6.5 Global Omega-3 Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Omega-3 Sales Value (2021-2032)
- 6.6.2 North America Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Omega-3 Sales Value (2021-2032)
- 6.7.2 Europe Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Omega-3 Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Omega-3 Sales Value (2021-2032)
- 6.9.2 South America Omega-3 Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Omega-3 Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Omega-3 Sales Value Share by Country, 2025 VS 2032
7 Omega-3 Country-level Sales and Value Analysis
- 7.1 Global Omega-3 Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Omega-3 Sales by Country (2021-2032)
- 7.3.1 Global Omega-3 Sales by Country (2021-2026)
- 7.3.2 Global Omega-3 Sales by Country (2027-2032)
- 7.4 Global Omega-3 Sales Value by Country (2021-2032)
- 7.4.1 Global Omega-3 Sales Value by Country (2021-2026)
- 7.4.2 Global Omega-3 Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Omega-3 Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Omega-3 Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Omega-3 Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Omega-3 Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Omega-3 Sales Value Growth Rate (2021-2032)
- 7.9.2 France Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Omega-3 Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Omega-3 Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Omega-3 Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Omega-3 Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Omega-3 Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Omega-3 Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Omega-3 Sales Value Growth Rate (2021-2032)
- 7.16.2 China Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Omega-3 Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Omega-3 Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Omega-3 Sales Value Growth Rate (2021-2032)
- 7.19.2 India Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Omega-3 Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Omega-3 Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Omega-3 Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Omega-3 Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Omega-3 Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Omega-3 Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Omega-3 Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Omega-3 Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Omega-3 Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Omega-3 Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Omega-3 Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Omega-3 Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Omega-3 Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Omega-3 Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Omega-3 Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Omega-3 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.1.4 DSM Omega-3 Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 BASF
- 8.2.1 BASF Company Information
- 8.2.2 BASF Business Overview
- 8.2.3 BASF Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.2.4 BASF Omega-3 Product Portfolio
- 8.2.5 BASF Recent Developments
- 8.3 EPAX
- 8.3.1 EPAX Company Information
- 8.3.2 EPAX Business Overview
- 8.3.3 EPAX Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.3.4 EPAX Omega-3 Product Portfolio
- 8.3.5 EPAX Recent Developments
- 8.4 Golden Omega
- 8.4.1 Golden Omega Company Information
- 8.4.2 Golden Omega Business Overview
- 8.4.3 Golden Omega Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Golden Omega Omega-3 Product Portfolio
- 8.4.5 Golden Omega Recent Developments
- 8.5 TASA
- 8.5.1 TASA Company Information
- 8.5.2 TASA Business Overview
- 8.5.3 TASA Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.5.4 TASA Omega-3 Product Portfolio
- 8.5.5 TASA Recent Developments
- 8.6 Omega Protein
- 8.6.1 Omega Protein Company Information
- 8.6.2 Omega Protein Business Overview
- 8.6.3 Omega Protein Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Omega Protein Omega-3 Product Portfolio
- 8.6.5 Omega Protein Recent Developments
- 8.7 Croda
- 8.7.1 Croda Company Information
- 8.7.2 Croda Business Overview
- 8.7.3 Croda Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Croda Omega-3 Product Portfolio
- 8.7.5 Croda Recent Developments
- 8.8 KD Pharma (Marine Ingredients)
- 8.8.1 KD Pharma (Marine Ingredients) Company Information
- 8.8.2 KD Pharma (Marine Ingredients) Business Overview
- 8.8.3 KD Pharma (Marine Ingredients) Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.8.4 KD Pharma (Marine Ingredients) Omega-3 Product Portfolio
- 8.8.5 KD Pharma (Marine Ingredients) Recent Developments
- 8.9 GC Rieber
- 8.9.1 GC Rieber Company Information
- 8.9.2 GC Rieber Business Overview
- 8.9.3 GC Rieber Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.9.4 GC Rieber Omega-3 Product Portfolio
- 8.9.5 GC Rieber Recent Developments
- 8.10 Polaris
- 8.10.1 Polaris Company Information
- 8.10.2 Polaris Business Overview
- 8.10.3 Polaris Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Polaris Omega-3 Product Portfolio
- 8.10.5 Polaris Recent Developments
- 8.11 Auqi
- 8.11.1 Auqi Company Information
- 8.11.2 Auqi Business Overview
- 8.11.3 Auqi Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Auqi Omega-3 Product Portfolio
- 8.11.5 Auqi Recent Developments
- 8.12 Kinomega
- 8.12.1 Kinomega Company Information
- 8.12.2 Kinomega Business Overview
- 8.12.3 Kinomega Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Kinomega Omega-3 Product Portfolio
- 8.12.5 Kinomega Recent Developments
- 8.13 Skuny
- 8.13.1 Skuny Company Information
- 8.13.2 Skuny Business Overview
- 8.13.3 Skuny Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Skuny Omega-3 Product Portfolio
- 8.13.5 Skuny Recent Developments
- 8.14 Xinzhou
- 8.14.1 Xinzhou Company Information
- 8.14.2 Xinzhou Business Overview
- 8.14.3 Xinzhou Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Xinzhou Omega-3 Product Portfolio
- 8.14.5 Xinzhou Recent Developments
- 8.15 Anti-Cancer
- 8.15.1 Anti-Cancer Company Information
- 8.15.2 Anti-Cancer Business Overview
- 8.15.3 Anti-Cancer Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Anti-Cancer Omega-3 Product Portfolio
- 8.15.5 Anti-Cancer Recent Developments
- 8.16 Sinomega
- 8.16.1 Sinomega Company Information
- 8.16.2 Sinomega Business Overview
- 8.16.3 Sinomega Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Sinomega Omega-3 Product Portfolio
- 8.16.5 Sinomega Recent Developments
- 8.17 Orkla Health
- 8.17.1 Orkla Health Company Information
- 8.17.2 Orkla Health Business Overview
- 8.17.3 Orkla Health Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Orkla Health Omega-3 Product Portfolio
- 8.17.5 Orkla Health Recent Developments
- 8.18 LYSI
- 8.18.1 LYSI Company Information
- 8.18.2 LYSI Business Overview
- 8.18.3 LYSI Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.18.4 LYSI Omega-3 Product Portfolio
- 8.18.5 LYSI Recent Developments
- 8.19 OLVEA Fish Oils
- 8.19.1 OLVEA Fish Oils Company Information
- 8.19.2 OLVEA Fish Oils Business Overview
- 8.19.3 OLVEA Fish Oils Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.19.4 OLVEA Fish Oils Omega-3 Product Portfolio
- 8.19.5 OLVEA Fish Oils Recent Developments
- 8.20 Hofseth BioCare
- 8.20.1 Hofseth BioCare Company Information
- 8.20.2 Hofseth BioCare Business Overview
- 8.20.3 Hofseth BioCare Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Hofseth BioCare Omega-3 Product Portfolio
- 8.20.5 Hofseth BioCare Recent Developments
- 8.21 Nippon Suisan Kaisha
- 8.21.1 Nippon Suisan Kaisha Company Information
- 8.21.2 Nippon Suisan Kaisha Business Overview
- 8.21.3 Nippon Suisan Kaisha Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Nippon Suisan Kaisha Omega-3 Product Portfolio
- 8.21.5 Nippon Suisan Kaisha Recent Developments
- 8.22 Bioprocess Algae
- 8.22.1 Bioprocess Algae Company Information
- 8.22.2 Bioprocess Algae Business Overview
- 8.22.3 Bioprocess Algae Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Bioprocess Algae Omega-3 Product Portfolio
- 8.22.5 Bioprocess Algae Recent Developments
- 8.23 Shandong Yuwang Pharmaceutical
- 8.23.1 Shandong Yuwang Pharmaceutical Company Information
- 8.23.2 Shandong Yuwang Pharmaceutical Business Overview
- 8.23.3 Shandong Yuwang Pharmaceutical Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Shandong Yuwang Pharmaceutical Omega-3 Product Portfolio
- 8.23.5 Shandong Yuwang Pharmaceutical Recent Developments
- 8.24 Maruha Nichiro Foods
- 8.24.1 Maruha Nichiro Foods Company Information
- 8.24.2 Maruha Nichiro Foods Business Overview
- 8.24.3 Maruha Nichiro Foods Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Maruha Nichiro Foods Omega-3 Product Portfolio
- 8.24.5 Maruha Nichiro Foods Recent Developments
- 8.25 Solutex
- 8.25.1 Solutex Company Information
- 8.25.2 Solutex Business Overview
- 8.25.3 Solutex Omega-3 Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Solutex Omega-3 Product Portfolio
- 8.25.5 Solutex Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Omega-3 Value Chain Analysis
- 9.1.1 Omega-3 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Omega-3 Sales Mode & Process
- 9.2 Omega-3 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Omega-3 Distributors
- 9.2.3 Omega-3 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst